NHS

NPA analysis finds over 6 million hours spent in A&E on cases treatable by community pharmacies

A new report by the National Pharmacy Association reveals that patients spent over 6 million hours in A&E last year for minor health issues that could have been managed by community pharmacies, highlighting an opportunity to ease pressure on emergency services.

The future of AI and the NHS

Dr Richard Ovens and Philip Brocklehurst from Deloitte navigate the future of AI and the NHS.

Driving digital transformation in health and social care: A modernised system

As the UK's health and social care systems continue to face growing pressure, techUK has published a set of strategic recommendations aimed at accelerating digital transformation across the sector.

Burosumab: The NHS has revealed a new therapy for people with rare bone disease

The NHS in England has introduced a new therapy that hopes to transform the lives of hundreds of adults living with X-linked Hypophosphatemia (XLH), this rare genetic disorder causes severe bone, dental, and skeletal issues.

Preventing sight loss for people with diabetes with new advanced eye scans

Providing advanced eye scans to people with diabetes could help in preventing sight loss for thousands whilst also freeing up NHS appointments.

DigiTrials: NHS patients will be contacted to volunteer for cancer research trials

The NHS is looking for volunteers as part of the three cancer projects that have been selected as part of the NHS DigiTrials initiative. Almost 150,000 volunteers will take part in these trials to help transform cancer treatment.

New NHS pill to help smokers quit

The NHS has introduced a 'stop smoking' pill to try and encourage people to quit.

Diagnosing efficiency: How detailed analysis drives NHS cancer care improvements

Gareth Jenkins, a partner at Changeology Group Ltd, discusses the potential of detailed analysis to enhance the efficiency of cancer care within the NHS.

Improving care for mental health patients

The UK government has reassessed the previously outdated Mental Health Act to promote treating patients more humanely and address disparities.

Securing Europe’s health future: The need for a safe blood supply

The regular supply of safe blood is crucial for health systems worldwide. In this article, the Blood Transfusion Association explains how the EU’s updated SoHO Regulation is impacting the sustainable and safe supply of life-saving blood products.

NHS England co-develops Framespan, the Framework Platform

Greg Jackson, Sales Manager at Framespan, discusses the recent endorsement of Framespan by NHS England and its role in supporting the commercial strategy of the NHS and wider public sector

UK Budget 2024: Chancellor Rachel Reeves announces tax rises and spending boosts

Chancellor Rachel Reeves has revealed several tax increases and spending plans to boost economic resilience while funding key public services.

Why the NHS is seeking to make patient media systems free

As more and more trusts refresh ageing patient media systems, they are also exploring ways to inform, educate and stimulate patients. Dean Moody, healthcare services director for Airwave Healthcare, explains why.

e-Invoicing: Some positive signs going into the autumn budget

As the UK government stares into a £22 Billion deficit black hole, and we all share the doom and gloom of potential tax rises in the autumn budget, there has at least been some positive news in the run-up to the 30th of October, and it should not be understated.

The future of health infrastructure: Building for a net zero NHS

Lorna Rothery spoke to Olivia Murphy-Fawcett, Head of Sustainability and Social Impact at NHS Shared Business Services, about how the UK’s health system is working to reduce its carbon emissions and reach a net zero NHS.

The role of a citizen-first approach to enable a preventative care future

The NHS is poised for a transformative shift with the launch of Change.NHS. By prioritising the needs of vulnerable individuals and leveraging existing assets, we can move towards a future where prevention is the norm, not the exception.

Donanemab: NHS rejects second promising drug for Alzheimer’s

A second groundbreaking drug for Alzheimer's disease has been rejected for widespread use by the NHS in England; according to the drugs spending watchdog, the drug known as Donanemab does not offer sufficient value for money.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders